• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » Screening Adolescent Patients for Substance Use

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Screening Adolescent Patients for Substance Use

July 19, 2018
Adolescents are generally healthy, and they don’t tend to present with pancreatitis or other adult diseases that can be possible clues to a substance use issue. A lot of times adolescents with SUDs don’t hit the surface until they have a legal or a school consequence.

The following is some advice on screening adolescents for SUDs from Joanna Quigley, MD, Associate Medical Director for Child and Adolescent Ambulatory Services at the University of Michigan, who we interviewed on the topic in the July/August issue of The Carlat Addiction Treatment Report:

Make use of screening tools
The electronic Screening to Brief Intervention (S2BI) looks at frequency of use. It screens for nicotine and tobacco, alcohol, marijuana, and others. The CRAFFT is also a great tool in general child psychiatry and addiction treatment practices. NIAAA also has a two-question test that looks at use.

Ask the right screening questions
Be very specific in your questions. Don’t just ask, “Do you smoke?” Ask, “Are you using any nicotine products? What are you using in your vape?” Adolescents are also adjusting the contents of some of these vape products to include cannabidiols and increasing the levels of nicotine.

For a specific medication, ask, “Have you ever found yourself taking more than you’re prescribed and how did that make you feel?” Ask substance-specific questions and very specific impairment questions such as, “How often are you thinking about using?” “Do you find yourself not getting as high as you used to?”

Consider motivational interviewing
Use motivational interviewing (MI) techniques while engaging around why they’re still using. For example, if it’s cannabis, find out what role the cannabis is playing in their lives. Oftentimes, we’ll discover there may be concurrent anxiety or an untreated mood disorder.

In utilizing MI, try to ask general questions to gauge their engagement with drugs and their beliefs. For example: “Your parents seem to be really worried about your substance use, what do you think about that?” Additionally, you could ask questions such as, “You state that you have researched a lot about cannabis and believe that its risks are overrated. Do you think there’s any evidence that your cannabis use has had a negative impact on your day to day life?”

Want to read the full Q&A? Click here. (Full article is available to The Carlat Addiction Treatment Report subscribers. Not a subscriber? Join here.)
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.